Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Fahim Amini, Sheli Rosenberg, Michael McGarrity, Andre de Bruin, and Others

Premium

BioNano Genomics has appointed Fahim Amini to serve as its new vice president of commercial operations for Europe, the Middle East, and Africa. In the role, he will be responsible for selling the company's Irys System into the EMEA markets.

Amini recently was director of EMEA at Complete Genomics, and before that, he played similar roles at Illumina and Affymetrix.


Nanosphere's shareholders have re-elected five members of its board of directors to continue serving until the next shareholder meeting in 2014, including: Sheli Rosenberg; Michael McGarrity; André de Bruin; Lorin Randall; and Michael Ward.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.